Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-313

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 68001-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9dca4f01-figure-01 (Azacitidine 1)

Chemical structure of azacitidine, shown as a molecular diagram with labeled atoms and bonds corresponding to its molecular framework.*

FDA Label Image

9dca4f01-figure-02 (Azacitidine 2)

A Kaplan-Meier survival curve chart depicting proportion surviving over time (months) from randomization for two groups: AZA (Azacitidine) and CCR. The chart shows the survival probability decreasing over time for both groups, with AZA having a higher survival proportion than CCR. Annotations include Log-Rank test p-value (0.0001), hazard ratio with confidence intervals, and number of deaths for each group. At-risk counts for each time point are also shown below the x-axis.*

FDA Label Image

Azacitidine Carton Rev 04-17 (Azacitidine 3)

Packaging label for Azacitidine injection, lyophilized powder, 100 mg per vial by BluePoint Laboratories. The label states it is for subcutaneous and intravenous infusion after reconstitution. It includes warnings of cytotoxicity, storage instructions, manufacturing details from Sindan Pharma SRL in Romania, and dosing references. The label also displays the product NDC 68001-313-56 and barcode.*

FDA Label Image

Azacitidine Inj_100mg_rev 09-16_bluepoint Label (Approved)

Label for Azacitidine for Injection 100 mg/vial lyophilized powder by BluePoint Laboratories. It indicates the product is for subcutaneous and intravenous infusion after reconstitution. The vial is sterile, nonpyrogenic, preservative-free, and single-dose. The label includes a cytotoxic agent caution and states it is manufactured in Romania by Sindan Pharma SRL for BluePoint Laboratories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.